1. Home
  2. SQNS vs APLT Comparison

SQNS vs APLT Comparison

Compare SQNS & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • APLT
  • Stock Information
  • Founded
  • SQNS 2003
  • APLT 2016
  • Country
  • SQNS France
  • APLT United States
  • Employees
  • SQNS N/A
  • APLT N/A
  • Industry
  • SQNS Semiconductors
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQNS Technology
  • APLT Health Care
  • Exchange
  • SQNS Nasdaq
  • APLT Nasdaq
  • Market Cap
  • SQNS 85.7M
  • APLT 80.3M
  • IPO Year
  • SQNS 2011
  • APLT 2019
  • Fundamental
  • Price
  • SQNS $3.12
  • APLT $0.62
  • Analyst Decision
  • SQNS Strong Buy
  • APLT Buy
  • Analyst Count
  • SQNS 1
  • APLT 7
  • Target Price
  • SQNS $7.50
  • APLT $6.10
  • AVG Volume (30 Days)
  • SQNS 118.6K
  • APLT 5.8M
  • Earning Date
  • SQNS 02-11-2025
  • APLT 03-05-2025
  • Dividend Yield
  • SQNS N/A
  • APLT N/A
  • EPS Growth
  • SQNS N/A
  • APLT N/A
  • EPS
  • SQNS 1.65
  • APLT N/A
  • Revenue
  • SQNS $30,555,000.00
  • APLT N/A
  • Revenue This Year
  • SQNS $10.14
  • APLT N/A
  • Revenue Next Year
  • SQNS $8.54
  • APLT $2,622.90
  • P/E Ratio
  • SQNS $1.99
  • APLT N/A
  • Revenue Growth
  • SQNS N/A
  • APLT N/A
  • 52 Week Low
  • SQNS $0.85
  • APLT $0.54
  • 52 Week High
  • SQNS $7.43
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 50.30
  • APLT 27.09
  • Support Level
  • SQNS $3.00
  • APLT $0.54
  • Resistance Level
  • SQNS $3.64
  • APLT $0.64
  • Average True Range (ATR)
  • SQNS 0.22
  • APLT 0.07
  • MACD
  • SQNS -0.01
  • APLT 0.12
  • Stochastic Oscillator
  • SQNS 34.78
  • APLT 31.65

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: